Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 29.04% is in line with its 5-year average of 31.66%, near the low end of its 5-year range (26.81%–35.61%).
1.32% below its 12-month average of 29.43%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 31.49%.
NET PROFIT MARGIN
29.04%
NET PROFIT MARGIN AVG TTM
29.43%
NET PROFIT MARGIN AVG 3Y
31.75%
NET PROFIT MARGIN AVG 5Y
31.66%
NET PROFIT MARGIN AVG 10Y
31.92%
NET PROFIT MARGIN AVG 15Y
30.03%
NET PROFIT MARGIN AVG 20Y
28.89%
CURRENT VS TTM AVG
-1.32%
CURRENT VS 3Y AVG
-8.53%
CURRENT VS 5Y AVG
-8.27%
CURRENT VS 10Y AVG
-9.02%
CURRENT VS 15Y AVG
-3.30%
CURRENT VS 20Y AVG
+0.52%
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+11269.23%
vs the sector median at left
Utah Medical Products, Inc.
Market Cap
$235.43M
Net Profit Margin
29.04%
TTM Avg
29.43%
3Y Avg
31.75%
5Y Avg
31.66%
Market Cap
$234.18M
Net Profit Margin
-5.14%
TTM Avg
33.66%
3Y Avg
36.64%
5Y Avg
40.60%
Market Cap
$237.16M
Net Profit Margin
-183.90%
TTM Avg
-383.83%
3Y Avg
-191.92%
5Y Avg
-127.94%
Market Cap
$231.99M
Net Profit Margin
-155582.08%
TTM Avg
-91683.52%
3Y Avg
-62749.43%
5Y Avg
-41832.95%
Market Cap
$234.48M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$237.84M
Net Profit Margin
-13.54%
TTM Avg
-22.79%
3Y Avg
-26.12%
5Y Avg
-61.39%
Market Cap
$238.57M
Net Profit Margin
-4.52%
TTM Avg
-4.68%
3Y Avg
-9.38%
5Y Avg
-10.81%
Market Cap
$239.35M
Net Profit Margin
-6138.26%
TTM Avg
-3731.55%
3Y Avg
-4082.97%
5Y Avg
-2721.98%
Market Cap
$231.49M
Net Profit Margin
-912.25%
TTM Avg
-448.06%
3Y Avg
-224.03%
5Y Avg
-224.03%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Utah Medical Products, Inc. (UTMD) | $235.43M | 29.04% | 29.43% | 31.75% | 31.66% |
| SIGA Technologies, Inc. (SIGA)vs › | $234.18M | -5.14% | 33.66% | 36.64% | 40.60% |
| Invivyd, Inc. (IVVD)vs › | $237.16M | -183.90% | -383.83% | -191.92% | -127.94% |
| InflaRx N.V. (IFRX)vs › | $231.99M | -155582.08% | -91683.52% | -62749.43% | -41832.95% |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $234.48M | 0.00% | 0.00% | 0.00% | 0.00% |
| Akebia Therapeutics, Inc. (AKBA)vs › | $237.84M | -13.54% | -22.79% | -26.12% | -61.39% |
| High Tide Inc. (HITI)vs › | $238.57M | -4.52% | -4.68% | -9.38% | -10.81% |
| Quantum-Si incorporated (QSI)vs › | $239.35M | -6138.26% | -3731.55% | -4082.97% | -2721.98% |
| BioAge Labs Inc. (BIOA)vs › | $231.49M | -912.25% | -448.06% | -224.03% | -224.03% |
| MacroGenics, Inc. (MGNX)vs › | $230.22M | -8.70% | -47.52% | -47.68% | -98.44% |
Operating Margin
28.5%
Net Profit Margin
29.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 31.49% |
| 2026-03-31 | 29.86% |
| 2025-12-31 | 28.36% |
| 2025-09-30 | 26.81% |
| 2025-06-30 | 30.62% |
| 2025-03-31 | 31.32% |
| 2024-12-31 | 31.69% |
| 2024-09-30 | 35.61% |
| 2024-06-30 | 33.20% |
| 2024-03-31 | 34.89% |
| 2023-12-31 | 34.75% |
| 2023-09-30 | 31.47% |
| 2023-06-30 | 32.64% |
| 2023-03-31 | 33.66% |
| 2022-12-31 | 33.56% |
| 2022-09-30 | 33.04% |
| 2022-06-30 | 30.56% |
| 2022-03-31 | 28.68% |
| 2021-12-31 | 32.00% |
| 2021-09-30 | 33.46% |
| 2021-06-30 | 27.18% |
| 2021-03-31 | 27.58% |
| 2020-12-31 | 28.41% |
| 2020-09-30 | 27.99% |
| 2020-06-30 | 14.94% |
| 2020-03-31 | 28.80% |
| 2019-12-31 | 36.84% |
| 2019-09-30 | 29.65% |
| 2019-06-30 | 29.76% |
| 2019-03-31 | 29.25% |
| 2018-12-31 | 34.78% |
| 2018-09-30 | 65.08% |
| 2018-06-30 | 39.29% |
| 2018-03-31 | 37.59% |
| 2017-12-31 | -24.72% |
| 2017-09-30 | 35.77% |
| 2017-06-30 | 35.74% |
| 2017-03-31 | 34.47% |
| 2016-12-31 | 30.69% |
| 2016-09-30 | 30.40% |
| 2016-06-30 | 31.07% |
| 2016-03-31 | 31.23% |
| 2015-12-31 | 33.51% |
| 2015-09-30 | 30.64% |
| 2015-06-30 | 28.07% |
| 2015-03-31 | 26.06% |
| 2014-12-31 | 29.29% |
| 2014-09-30 | 26.33% |
| 2014-06-30 | 27.01% |
| 2014-03-31 | 27.70% |
| 2013-12-31 | 34.39% |
| 2013-09-30 | 25.63% |
| 2013-06-30 | 26.31% |
| 2013-03-31 | 26.36% |
| 2012-12-31 | 22.97% |
| 2012-09-30 | 25.94% |
| 2012-06-30 | 23.95% |
| 2012-03-31 | 24.89% |
| 2011-12-31 | 18.76% |
| 2011-09-30 | 20.74% |
| 2011-06-30 | 19.10% |
| 2011-03-31 | 19.67% |
| 2010-12-31 | 24.30% |
| 2010-09-30 | 24.38% |
| 2010-06-30 | 23.37% |
| 2010-03-31 | 23.73% |
| 2009-12-31 | 23.83% |
| 2009-09-30 | 24.20% |
| 2009-06-30 | 23.85% |
| 2009-03-31 | 24.70% |
| 2008-12-31 | 23.90% |
| 2008-09-30 | 25.34% |
| 2008-06-30 | 26.94% |
| 2008-03-31 | 27.45% |
| 2007-12-31 | 27.63% |
| 2007-09-30 | 28.48% |
| 2007-06-30 | 27.53% |
| 2007-03-31 | 27.31% |
| 2006-12-31 | 28.14% |
| 2006-09-30 | 28.61% |
| 2006-06-30 | 28.23% |
| 2006-03-31 | 28.66% |
| 2005-12-31 | 27.13% |
| 2005-09-30 | 25.55% |
| 2005-06-30 | 26.85% |
| 2005-03-31 | 29.60% |
| 2004-12-31 | 21.92% |
| 2004-09-30 | 27.09% |
| 2004-06-30 | 26.97% |
| 2004-03-31 | 78.22% |
| 2003-12-31 | 229.39% |
| 2003-09-30 | 27.53% |
| 2003-06-30 | 26.86% |
| 2003-03-31 | 26.00% |
| 2002-12-31 | 26.05% |
| 2002-09-30 | 26.88% |
